--- title: "Kuo Kuang Biotechnology collaborates with the South Link Foundation to deliver flu vaccines to rural areas in Taitung" type: "News" locale: "en" url: "https://longbridge.com/en/news/228519413.md" description: "Kuo Kuang Biotechnology collaborates with the Southbound Foundation to send 500 doses of flu vaccine to rural areas in Taitung every year. Due to a surge in vaccination demand, Kuo Kuang Biotechnology has decided to add another 300 doses of vaccine to ensure that residents in rural areas can receive timely vaccinations. The flu vaccination program at the Southbound Clinic will start on December 5, 2024, covering areas such as Daren, Dawu, Taimali, and Jin Feng, with all residents aged 18 and above eligible for free vaccination. Kuo Kuang Biotechnology stated that it will continue to support rural healthcare and plans to send another 500 doses of vaccine in the autumn and winter seasons" datetime: "2025-02-17T07:20:37.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/228519413.md) - [en](https://longbridge.com/en/news/228519413.md) - [zh-HK](https://longbridge.com/zh-HK/news/228519413.md) --- # Kuo Kuang Biotechnology collaborates with the South Link Foundation to deliver flu vaccines to rural areas in Taitung Kuo Guang Biotech (4142) has partnered with the Nankai Foundation to send 500 doses of flu vaccine to rural areas in Taitung every year. Since December last year, the Nankai Foundation's Nankai Clinic has completed 16 community flu vaccination events. Due to a recent surge in vaccinations, the vaccine supply is running low. On the 17th, Kuo Guang Biotech announced that the company has decided to add another 300 doses of flu vaccine directly to the Nankai Clinic, working together with the Nankai Foundation to protect the rural areas of Taitung, ensuring that residents in Daren, Dawu, Taimali, and Jin Feng can access vaccines regardless of distance. Influenced by the news of the sudden passing of Big S due to influenza, there has been a rush for flu vaccinations across Taiwan, and the Nankai Clinic has also set a record for the highest number of flu vaccinations in a single day, with the vaccine supply about to run out. Kuo Guang Biotech learned that the flu vaccine stock at the Nankai Clinic was critically low and decided to prioritize providing 300 doses of flu vaccine to the Nankai Foundation, ensuring the fastest delivery to the Nankai Clinic. Kuo Guang Biotech stated that this initiative aims to allow residents in rural Taitung to obtain vaccines first during this vaccination rush, adhering to the original intention of protecting Taiwan, and working with the Nankai Foundation to bring vaccines to the most remote areas of Taitung, ensuring that the elderly and vulnerable residents who need vaccines can receive them as quickly as possible. The flu vaccination program at the Nankai Clinic, sponsored by Kuo Guang Biotech, will officially launch on December 5, 2024. All medical staff at the Nankai Clinic will be mobilized to hold the first event at the Shangwu Village Community Activity Center, led by Dr. Hsu Chao-Pin, the director of the Nankai Clinic, who will conduct pre-vaccination health assessments and consultations. The three-month program also invites Dr. Lin Gao-Chang, a consultant neurologist from Chi Mei Medical Center, and Dr. Chou Meng-Hua from National Taiwan University Jiayi Clinic for support, totaling 16 events, reaching deeper into Taimali Duoliang, Jinlun, Daxi, and Langbu villages, achieving remarkable results. The benefiting areas include Daren, Dawu, Taimali, and Jin Feng, with residents over 18 eligible for free vaccinations. Kuo Guang Biotech stated that as a local vaccine manufacturer, it prioritizes Taiwan, especially the disadvantaged, and will continue to provide warmth to rural areas during the cold winter. This autumn and winter flu season, they will send another 500 doses of flu vaccine to Nankai, continuing to work alongside the Nankai Foundation to protect the most remote residents. This public welfare donation program for flu vaccines by the Nankai Foundation and Kuo Guang Biotech was facilitated by Kuo Guang Biotech Chairman Zhan Qi-Xian, based not only on a 20-year friendship with Dr. Hsu Chao-Pin, the founder of the Nankai Foundation, but also due to long-term attention to rural healthcare, where residents are often economically disadvantaged and have difficulty accessing hospitals and timely vaccines. Through the Nankai Foundation's comprehensive home healthcare and support, vaccines are delivered to their hometowns, not only supporting Dr. Hsu's medical intentions but also hoping to join forces to accompany the Nankai Foundation in safeguarding the health of Nankai residents. !\[\](https://imageproxy.pbkrs.com/https://pgw.udn.com.tw/gw/photo.php/query-dT1odHRwczovL3VjLnVkbi5jb20udHcvcGhvdG8vMjAyNS8wMi8xNy9yZWFsdGltZS8zMTUxMDUzNC5qcGcmeD0wJnk9MCZzdz0wJnNoPTAmc2w9VyZmdz0xMDUwJmV4cD0zNjAwJmV4cD0zNjAw? Guoguang Biotech collaborates with the Nankai Foundation to send 500 doses of flu vaccine to rural areas in Taitung every year. Since December last year, the Nankai Foundation's Nankai Clinic has completed 16 community flu vaccination events. Guoguang Biotech / Provided ### Related Stocks - [301207.CN](https://longbridge.com/en/quote/301207.CN.md) ## Related News & Research - [09:10 ETInSite BUILD Ranks No. 28 on the 2026 Inc. 5000 list](https://longbridge.com/en/news/295670741.md) - [Tecnovatica Announces Major Shareholder With 27.73% Stake After Capital Increase](https://longbridge.com/en/news/295802125.md) - [Nampak director Fullerton executes share collar hedge valued at R16 million](https://longbridge.com/en/news/295792017.md) - [Five killed while defusing explosive device in Russian-controlled Sevastopol, governor says](https://longbridge.com/en/news/295780996.md) - [Resilient REIT 1H FY26 basic earnings per share climb 57.26% to 278.85 cents; revenue rises to R 1.99 billion](https://longbridge.com/en/news/295685500.md)